Peter Zeihan: Europe Goes Nuclear
We’ve got two major developments in Eurasia. We’re talking about Ukraine disabling two ships in the Caspian Sea and Poland getting EU approval to build…
Thought Leader: Peter Zeihan
By Scott Gottlieb (Original source Fierce Biotech)
“Scott Gottlieb’s relatively short two-year tenure as the FDA’s head has ended, and we have a new man at the helm: Ned Sharpless. However, he used his first official talk to ensure we all know he’s not looking to tear up Gottlieb’s legacy.
Gottlieb, in fact, denied to reporters at the start of the year that he was leaving, but a few short months later he announced he was doing exactly that (citing commuting times), and then preceded to have the world’s longest goodbye tour. Fitting, I suppose, for a rock’n’roll FDA commissioner.
Gottlieb was praised by many in the bio Twitter sphere, as well as by President Donald Trump, the man who appointed him as FDA commissioner. Some areas, though, namely the opioid crisis and the surge in an anti-vaxxer movement, which has also seen a related spike in measles cases in the U.S., are still areas the FDA must get a grip on.”
Click here to see more
Peter Zeihan: Europe Goes Nuclear
We’ve got two major developments in Eurasia. We’re talking about Ukraine disabling two ships in the Caspian Sea and Poland getting EU approval to build…
Thought Leader: Peter Zeihan
Dr. Sanjay Gupta’s Top Health Stories of 2025
From the resurgence of measles to a new way to treat pain, 2025 was a challenge for public health while still offering moments of hope. Sanjay…
Thought Leader: Sanjay Gupta
Ian Bremmer: The state of global conflict in 2025
On GZERO World, Ian Bremmer takes a hard look at the biggest global crises and conflicts that defined our world in 2025 with CNN’s Clarissa…
Thought Leader: Ian Bremmer